研究表明,早期使用 Statins 和 ezetimibe 可以降低 未来心脏问题的风险 后心脏病发作后。 Study shows early use of statins and ezetimibe cuts risk of future heart issues post-heart attack.

一项新的研究表明,对心脏病发作的病人结合使用Statins和ezetimibe早早,可以大大降低今后心脏病和死亡的风险。 A new study suggests that giving heart attack patients a combination of statins and ezetimibe early can significantly lower the risk of future heart problems and death. 研究人员发现,在2015至2022年期间心脏病发作的36 000名瑞典病人中,在12周内开始综合治疗的病人有较好的结果。 Researchers found that among 36,000 Swedish patients who had heart attacks between 2015 and 2022, those who started the combined treatment within 12 weeks had better outcomes. 这种具有成本效益的治疗有可能防止数千起新的心脏病发作,导致研究人员呼吁改变全球医疗准则。 The cost-effective treatment could potentially prevent thousands of additional heart attacks, leading researchers to call for changes in global medical guidelines.